Cytochrome oxidase in Alzheimer's disease: Biochemical, histochemical, and immunohistochemical analyses of the visual and other systems

Vision Research

Volumn 37, Issue 24, 1997, Pages 3593-3608

  Wong Riley, Margaret ^a   Antuono, Piero ^a   Ho, Khang Cheng ^a   Egan, Robert ^a   Hevner, Robert ^a,b   Liebl, Wendy ^a   Huang, Zifang ^a   Rachel, Rivka ^a,c   Jones, Jenny ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c College of Physicians and Surgeons ^*  (United States)

Author keywords

Alzheimer's disease; Cortex; Cytochrome oxidase; LGN; Mitochondria

Indexed keywords

CYTOCHROME C OXIDASE;

AEROBIC METABOLISM; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; HUMAN; HUMAN TISSUE; LATERAL GENICULATE BODY; PRIORITY JOURNAL; VISUAL CORTEX; VISUAL SYSTEM;

ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; DENSITOMETRY; ELECTRON TRANSPORT COMPLEX IV; GENICULATE BODIES; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; OXIDATION-REDUCTION; SENILE PLAQUES; VISUAL CORTEX;

EID: 0030830677     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6989(96)00210-6     Document Type: Article

References (68)

1. Alberts, M. J., Ioannou, P., Deucher, R., Gilbert, J., Lee, J., Middleton, L. & Roses, A. D. (1992). Isolation of a cytochrome oxidase gene overexpressed in Alzheimer's disease brain. Molecular and Cellular Neuroscience, 3, 461-470.
2. Alzheimer, A. (1907). Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift fur Psychiatrie und Psychisch-Gerichtliche Medizin, 64, 146-148.
3. Appel, S. (1981). A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Annals of Neurology, 20, 499-505.
4. Bassi, C. J., Solomon, K. & Young, D. (1993). Vision in aging and dementia. Optometry and Vision Science, 70, 809-813.
5. Baudier, J. & Cole, R. D. (1987). Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. Journal of Biological Chemistry, 262, 17577-17583.
6. Beach, T. G. & McGeer, E. G. (1992). Senile plaques, amyloid β-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex. Acta Neuropathologica, 83, 292-299.
7. Beal, M. F. (1992). Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Annals of Neurology, 31, 119-130.
8. Blass, J. P., Baker, A. C., Ko, L.-W. & Black, R. S. (1990). Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Archives of Neurology, 47, 864-869.
9. Blass, J. P. & Gibson, G. E. (1991). The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Revue Neurologique (Paris), 147, 513-525.
10. Chandrasekaran, K., Giordano, T., Brady, D. R., Stoll, J., Martin, L. J. & Rapoport, S. I. (1994). Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Research Molecular Brain Research, 24, 336-340.
11. Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., McKee, A. C., Beal, M. F., Graham, B. H., Wallace, D. C. (1994). Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics, 23, 471-476.
12. Cronin-Golomb, A., Corkin, S., Rizzo, J. F., Cohen, J., Growdon, J. H. & Banks, K. S. (1991). Visual dysfunction in Alzheimer's disease: relation to normal aging. Annals of Neurology, 29, 41-52.
13. 18F]2-deoxy-d-glucose: healthy aging, Alzheimer's disease and Down syndrome. Progress in NeuroPsychopharmacology and Biological Psychiatry, 10, 309-321.
14. Duara, R., Grady, C., Haxby, J., Sundaram, M., Cutler, N. R., Heston, L., Moore, A., Schlageter, N., Larson, S., Rapoport, S. I. (1986). Positron emission tomography in Alzheimer's disease. Neurology, 36, 879-887.
15. Epelbaum, J., Apert, C. & Dournaud, P. (1993). Molecular basis of Alzheimer's disease. In Galteau, M.-M., Siest, G. & Henny, J. (Eds), Biologie prospective. Comptes rendus du 8. Colloque de Pont-a-Mousson (pp. 601-606). Paris: John Libbey Eurotext.
16. Gibson, G. E., Peterson, C. & Freeman, G. (1987). Alterations in neurotransmitter metabolism and calcium homeostasis during aging and Alzheimer's disease. Molecular Neuropathology of Aging, Banbury Reports, 27, 89-96.
17. Grady, C. L., Haxby, J. V., Horwitz, B., Gillette, J , Salerno, J. A., Gonzalez-Aviles, A., Carson, R. E., Herscovitch, P., Schapiro, M. B., Rapoport, S. I. (1993). Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiology of Aging, 14, 35-44.
18. Han, S.-H., Einstein, G., Weisgraber, K. H., Strittmatter, W. J., Saunders, A. M., Pericak-Vance, M., Roses, A. D., Schmechel, D. E. (1994). Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. Journal of Neuropathology and Experimental Neurology, 53, 535-544.
19. Haxby, J. V. & Rapoport, S. I. (1986). Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment. Progress in Neuro-psychopharmacology and Biological Psychiatry, 10, 427-438.
20. Heiss, W.-D., Szelies, B., Kessler, J. & Herholz, K. (1991). Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Annals of the New York Academy of Sciences, 640, 65-71.
21. Hevner, R. F. & Wong-Riley, M. T. T. (1989). Brain cytochrome oxidase: purification, antibody generation, and immunohistochemical/histochemical correlations in the CNS. Journal of Neuroscience, 9, 3884-3898.
22. Hevner, R. F. & Wong-Riley, M. T. T. (1992). Entorhinal cortex of the human, monkey, and rat: metabolic map as revealed by cytochrome oxidase. Journal of Comparative Neurology, 326, 451-469.
23. Hevner, R. F., Liu, S. & Wong-Riley, M. T. T. (1993). An optimized method for determining cytochrome oxidase activity in brain tissue homogenates. Journal of Neuroscience Methods, 50, 309-319.
24. Hof, P. R. & Bouras, C. (1991). Object recognition deficit in Alzheimer's disease: possible disconnection of the occipitotemporal component of the visual system. Neuroscience Letters, 122, 53-56.
25. Horwitz, B., Grady, C. L., Schlageter, N. L., Duara, R. & Rapoport, S. I. (1987). Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Research, 407, 294-306.
26. Hutton, J. T., Morris, J. L., Elias, J. W. & Poston, J. N. (1993). Contrast sensitivity dysfunction in Alzheimer's disease. Neurology, 43, 2328-2330.
27. Jagust, W. J., Friedland, R. P., Budinger, T. F., Koss, E. & Ober, B. (1988). Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology, 38, 909-912.
28. Johnson, K. A., Mueller, S. T., Walshe, T. M., English, R. J. & Holman, B. L. (1987). Cerebral perfusion imaging in Alzheimer's disease. Archives of Neurology, 44, 165-168.
29. Kageyama, G. H. & Wong-Riley, M. T. T. (1982). Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways. Neuroscience, 7, 2337-2361.
30. Kessler, J., Herholz, K., Grand, M. & Heiss, W. D. (1991). Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition. Neuropsychologia, 29, 229-243.
31. Khachaturian, Z. (1985). Diagnosis of Alzheimer's disease. Archives of Neurology, 42, 1097-1105.
32. Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L.-J., Wilson, J. M., DiStefano, L. M., Nobrega, J. N. (1992). Brain cytochrome oxidase in Alzheimer's disease. Journal of Neurochemistry, 59, 776-779.
33. Kurylo, D. D., Corkin, S., Dolan, R. P., Rizzo, J. F. 3rd, Parker, S. W. & Growdon, J. H. (1994). Broad-band visual capacities are not selectively impaired in Alzheimer's disease. Neurobiology of Aging, 15, 305-311.
34. Leuba, G. & Kraftsik, R. (1994). Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks. Neurobiology of Aging, 15, 29-43.
35. Levine, D. N., Lee, J. M. & Fisher, C. M. (1993). The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology, 43, 305-313.
36. Lin, F.-H., Lin, R., Wisniewski, H. M., Hwang, Y.-W., Grundke-Iqbal, I., Healy-Louie, G., Iqbal, K. (1992). Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochemical and Biophysical Research Communications, 182, 238-246.
37. Liu, S. & Wong-Riley, M. (1990). Quantitative light-and electron-microscopic analysis of cytochrome-oxidase distribution in neurons of the lateral geniculate nucleus of the adult monkey. Visual Neuroscience, 4, 269-287.
38. McGeer, E. G., McGeer, P. L., Harrop, R., Akiyama, H. & Kamo, H. (1990). Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's disease. Journal of Neuroscience Research, 27, 612-619.
39. Mendola, J. D., Cronin-Golomb, A., Corkin, S. & Growdon, J. H. (1995). Prevalence of visual deficits in Alzheimer's disease. Optometry and Vision Science, 72, 155-167.
40. Muller-Hill, B. & Beyreuther, K. (1989). Molecular biology of Alzheimer's disease. Annual Review of Biochemistry, 58, 287-307.
41. Mutisya, E. M., Bowling, A. C. & Beal, M. F. (1994). Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. Journal of Neurochemistry, 63, 2179-2184.
42. 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. Journal of Neurology, Neurosurgery and Psychiatry, 54, 672-678.
43. Pantel, J. (1995). Alzheimer's disease presenting as slowly progressive aphasia and slowly progressive visual agnosia: two early reports. Archives of Neurology, 52, 10.
44. Parker, W. D. & Parks, J. K. (1995). Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurology, 45, 482-486.
45. Parker, W. D., Boyson, S. J. & Parks, J. K. (1989). Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Annals of Neurology, 26, 719-723.
46. Parker, W. D., Filley, C. M. & Parks, J. K. ( 1990). Cytochrome oxidase deficiency in Alzheimer's disease. Neurology, 40, 1302-1303.
47. Parker, W. D., Mahr. N. J., Filley, C. M., Parks, J. K., Hughes. D., Young, D. A. & Cullum, C. M. (1994a) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology, 44, 1086-1090.
48. Parker, W. D., Parks, J., Filley, C. M. & Kleinschmidt-DeMasters, B. K. (1994b) Electron transport chain defects in Alzheimer's disease brain. Neurology, 44, 1090-1096.
49. Pearson, R. C. A., Esiri, M. M., Hiorns, R. W., Wilcock, G. K. & Powell, T. P. S. (1985). Anatomical correlates of the pathological changes in the neocortex in Alzheimer's disease. Proceedings of the National Academy of Sciences USA, 82, 4531-4534.
50. Rapoport, S. I. (1991). Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. Cerebrovascular and Brain Metabolism Reviews, 3, 297-335.
51. Reichmann, H., Florke, S., Hebenstreit, G., Schrubar, H. & Riederer, P. (1993). Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease. Journal of Neurology, 240, 377-380.
52. Rogers, J. & Morrison, J. H. (1985). Quantitative morphology and regional laminar distributions of senile plaques in Alzheimer's disease. Journal of Neuroscience, 5, 2801-2802.
53. Selkoe, D. J. (1991). The molecular pathology of Alzheimer's disease. Neuron, 6, 487-498.
54. Simonian, N. A. & Hyman, B. T. (1993). Functional alteration in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation. Journal of Neuropathoiogy and Experimental Neurology, 52, 580-585.
55. Simonian, N. A. & Hyman, B. T. (1994). Functional alteration in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. Journal of Neuropathoiogy and Experimental Neurology, 53, 508-512.
56. Tootell, R. B. H., Silverman, M. S., Hamilton, S. L., Switkes, E. & DeValois, R. L. (1988). Functional anatomy of macaque striate cortex. V. Spatial frequency. Journal of Neuroscience, 8, 1610-1624.
57. Trick, G. L., Trick, L. R., Morris, P. & Wolf, M. (1995). Visual field loss in senile dementia of the Alzheimer's type. Neurology, 45, 68-74.
58. Uhlmann, R. F., Larson, E. B., Koepsell, T. D., Rees, T. S. & Duckert, L. G. (1991). Visual impairment and cognitive dysfunction in Alzheimer's disease. Journal of General Internal Medicine, 6, 126-132.
59. Van Hoesen, G. W., Hyman, B. T. & Damasio, A. R. (1991). Entorhinal cortex pathology in Alzheimer's disease. Hippocampus, 1, 1-8.
60. Van Zuylen, A. J., Bosnian, G. J. C. G. M., Ruitenbeek, W., Van Kalmthout, P. J. C. & De Grip, W. J. (1992). No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease. Neurology, 42, 1246-1247.
61. Vermersch, P., Frigard, B. & Delacourte, A. (1992). Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathologica, 85, 48-54.
62. Volicer, L. & Crino, P. B. (1990). Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiology of Aging, 11, 567-571.
63. Wallace, D. C. (1992). Mitochondrial genetics: a paradigm for aging and degenerative diseases?. Science, 256, 628-632.
64. Wong-Riley, M. (1979). Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Research, 171, 11-28.
65. Wong-Riley, M. T. T. (1989). Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends in Neuroscience, 12, 94-101.
66. Wong-Riley, M. T. T. (1994). Primate visual cortex: dynamic metabolic organization and plasticity revealed by cytochrome oxidase. In Peters, A. & Rockland, K. (Eds), Cerebral cortex, Vol. 10. Primary visual cortex in primates (pp. 141-200). New York: Plenum Press.
67. Wong-Riley, M. T. T., Hevner, R. F., Cutlan, R., Earnest, M., Egan, R., Frost, J. & Nguyen, T. (1993). Cytochrome oxidase in the human visual cortex: distribution in the developing and the adult brain. Visual Neuroscience, 10, 41-58.
68. Wurtman, R. J. (1992). Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends in Neurosciences, 15, 117-122.